Amphetamine Sulfate (amphetamine) NDC 69238-1564

NDC codes

FDA NDC Directory

Product NDC (as listed)69238-1564Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69238-1564Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69238-1564-1	69238156401	100 TABLET in 1 BOTTLE (69238-1564-1)Marketed from Sep 28, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Amphetamine Sulfate
Generic name (nonproprietary): amphetamine
Active ingredients: Amphetamine sulfate — 10 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Amneal Pharmaceuticals NY LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211139
Marketing start: Sep 28, 2018
Listing expires: Dec 31, 2026
DEA schedule: CII
Other FDA classes: Central Nervous System Stimulation (Physiologic effect)
Identifiers: Product ID 69238-1564_940571ac-35e3-426e-8eb0-386a3987c3b9SPL ID 940571ac-35e3-426e-8eb0-386a3987c3b9SPL set ID 53d40847-e0d3-48ec-81a7-ec5478553565RxCUI 884655, 1600695UNII 6DPV8NK46S
Pharmacologic class: Central Nervous System Stimulant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469238156401 followed by a unit qualifier and the quantity

Package 69238-1564-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 1, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Amphetamine sulfate tablets, USP 5 mg and 10 mg are indicated for: 1. Narcolepsy 2. Attention Deficit Disorder with Hyperactivity as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. The diagnosis of the syndrome should not be made with finality when these symptoms are only of comparatively recent origin. Nonlocalizing (soft) neurological sig…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211139

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211139
Product	Strength	Form · route	Labeler	Product NDC
Amphetamine Sulfateamphetamine	Amphetamine sulfate 5 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	69238-1563